ZIMV (ZimVie) Interest Expense : $-18.1 Mil (TTM As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is ZimVie Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. ZimVie's interest expense for the three months ended in Mar. 2025 was $ -4.1 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2025 was $-18.1 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. ZimVie's Operating Income for the three months ended in Mar. 2025 was $ 3.7 Mil. ZimVie's Interest Expense for the three months ended in Mar. 2025 was $ -4.1 Mil. ZimVie's Interest Coverage for the quarter that ended in Mar. 2025 was 0.90. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

ZimVie Interest Expense Historical Data

The historical data trend for ZimVie's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ZimVie Interest Expense Chart

ZimVie Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-0.30

-0.41

-11.08

-22.75

-18.89

ZimVie Quarterly Data
	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Interest Expense	Get a 7-Day Free Trial														-4.87	-5.07	-4.83	-4.12	-4.05

ZimVie Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-18.1 Mil.

ZimVie (NAS:ZIMV) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

ZimVie's Interest Expense for the three months ended in Mar. 2025 was $-4.1 Mil. Its Operating Income for the three months ended in Mar. 2025 was $3.7 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2025 was $228.9 Mil.

ZimVie's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2025 )	/	Interest Expense (Q: Mar. 2025 )
	=	-1	*	3.661	/	-4.052
	=	0.90

The higher the ratio, the stronger the company's financial strength is.

ZimVie Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ZimVie Inc (NAS:ZIMV) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

O23:Germany

Address

4555 Riverside Drive, Palm Beach Gardens, Florida, DE, USA, 33410

Website

https://www.zimvie.com

ZimVie Inc is focused on the dental and spine markets and their respective growth drivers such as implants, surgical tools, bone graft substitutes, spinal fusion implants, non-fusion alternatives, and digital care management solutions. Business is organized into two operating segments the spine products segment and the dental products segment.

Executives

Camber Capital Management Lp	10 percent owner	101 HUNTINGTON AVENUE, SUITE 2101, BOSTON MA 02199
Sally Crawford	director	C/O HOLOGIC, INC., BEDFORD MA 01730
Vafa Jamali	director, officer: See Remarks	C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Richard Heppenstall	officer: See Remarks	C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Zimmer Biomet Holdings, Inc.	10 percent owner	345 EAST MAIN STREET, WARSAW IN 46580
Richard Kuntz	director	MEDTRONIC, INC., 710 MEDTRONIC PWKY MS LC 310, MINNEAPOLIS MN 55432
Vinit K Asar	director	10910 DOMAIN DRIVE, SUITE 300, AUSTIN TX 78758
Karen Matusinec	director	C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
David P King	director	PRIVIA HEALTH GROUP, INC., 950 N. GLEBE RD., SUITE 700, ARLINGTON VA 22203
Rebecca Ann Whitney	officer: See Remarks	10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
David John Harmon	officer: See Remarks	10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Indraneel Kanaglekar	officer: See Remarks	C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Heather Kidwell	officer: See Remarks	C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021
Sandra Schneider	officer: Chief Accounting Officer	C/O ZIMVIE INC., 10225 WESTMOOR DRIVE, WESTMINSTER CO 80021